Not investment advice. Educational platform. See Disclaimer.
NASDAQ: IMA
ImageneBio Inc
Healthcare | Biotechnology
No licensed closing price on file for IMA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
ImageneBio Inc (NASDAQ: IMA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 05:08 UTC.
2026-07-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-10-22Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-10-10Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
ImageneBio Inc is a biotechnology company, listed on NASDAQ as IMA.
When did IMA last file with the SEC?
ImageneBio Inc's most recent SEC filing on record is a 8-K filed 2026-06-26. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:08 UTC. This page is also available as JSON at /api/data?ticker=IMA and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for IMA and 5,000+ tickers.